Darya Chudova - 15 May 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Issuer symbol
GH
Transactions as of
15 May 2024
Net transactions value
-$79,980
Form type
4
Filing time
16 May 2024, 18:12:12 UTC
Previous filing
02 Apr 2024
Next filing
03 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +8,705 +23% $0.000000 46,106 15 May 2024 Direct
transaction GH Common Stock Tax liability $79,980 -3,106 -6.7% $25.75 43,000 15 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -8,705 -25% $0.000000 26,116 15 May 2024 Common Stock 8,705 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This represents a restricted stock unit award granted on August 7, 2023 and vests over a four-year period. 25% of the shares subject to such award vests on the one-year anniversary of May 15, 2023, and the remaining 75% vests annually during the three-year period thereafter.
F3 Not applicable for Restricted Stock Units.

Remarks:

Table I, includes 1,097 shares acquired under Guardant Health's Employee Stock Purchase Plan on 5/14/2024.